期刊文献+

脓毒症致凝血异常发生机制的研究进展 被引量:15

Research Progress on the Mechanism of Coagulopathy in Sepsis
原文传递
导出
摘要 脓毒症是由感染引起的全身炎症反应综合征,其病情凶险,死亡率高。凝血异常是脓毒症的主要特点之一,是多方面因素共同作用的结果。在脓毒症的发生发展过程中,炎症因子既可以激活凝血级联反应又可以抑制抗凝系统和纤维蛋白溶解系统,最终导致其凝血活性增强,炎症诱导的凝血紊乱进一步促进和加重炎症反应。而脓毒症患者的高凝状态可导致静脉血栓栓塞甚至DIC的发生,引起了研究者们的广泛关注。本文将就脓毒症致凝血异常发生机制的研究进展做一综述。 Sepsis is a systemic inflammatory response syndrome to presumed or known infection,which is an extensive clinical problem with high mortality. Disturbance of blood coagulation is one of the main characteristics of sepsis, which is the consequence of various affects together. In the development of sepsis, inflammatory cytokines both activate the coagulation cascade and inhibit anticoagulant mechanisms and fibrinolysis, which eventually results in the enhancement of procoagulant activity. Inflammation-induced coagulation further aggravate the inflammatory response. Hypercoagulability in sepsis may contribute to venous thromboembolism or disseminated intravascular coagulation(DIC). This article is aimed to review the research progress on the mechanism of coagulopathy in sepsis.
出处 《现代生物医学进展》 CAS 2015年第11期2148-2149,2160,共3页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(81270588)
关键词 脓毒症 凝血功能异常 炎症 血栓栓塞 Sepsis Coagulopathy Inflammation Thromboembolism
  • 相关文献

参考文献23

  • 1Semeraro N, Ammollo CT, Semeraro F, et al. Sepsis, thrombosis and organ dysfunction [J]. Thromb Res, 2012, 129(3): 290-295.
  • 2Petaja J. Inflammation and coagulation [J]. Thromb Res, 2011, 127 (Suppl 2): $34-37.
  • 3Camerer E, Kolsto AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation [J]. Thromb Res, 1996, 81(1): 1-41.
  • 4Osterud B. Tissue factor/TFPI and blood cells [J]. Thromb Res, 2012, 129(3): 274-278.
  • 5N Semeraro CT, Ammollo F, Semeraro M, et al. Sepsis- associated disseminated intravascular coagulation and throm- boembolie disease [J]. Mediterr J Hematol Infect Dis, 2010, 2(3): e2010024.
  • 6Akca S, Haji-Michael P, de Mendonca, A, et al. Time course of platelet cotmts in critically ill patients [J]. Crit Care Med, 2002, 30(4): 753-756.
  • 7Zimmerman GA, Mclntyre TM, Prescott SM, et al. The platelet-activating factor signaling system and its regulators in syndromes of inflammation and thrombosis [J]. Crit. Care Med, 2002, 30(5): $294-$301.
  • 8Del Conde I, Shrimpton CN, Thiagarajan P, et al. Tissue-factor-bearing microves icles arise from lipid rafts and fuse with activated platelets to initiate coagulation [J]. Blood, 2005, 106 (5): 1604-1611.
  • 9Bombeli T, Mueller M, Haeberli A. Anticoagulant properties of the vascular endothelium [J]. Thromb Haemost. 1997, 77(3): 408-423.
  • 10Schouten M, Wiersinga WJ, Levi M, et al. Inflammation, endothelium, and coagulation in sepsis [J]. J Leukoc Biol, 2008, 83 (3): 536-545.

二级参考文献20

  • 1Panes O, Matus V, Saez CG, et al. Human platelets synthesize and express functional tissue factor. Blood, 2007, 109: 5242- 5250.
  • 2Wang X, Wang J, Genqvo-Ando K, et al. C. elegans mitochon- drial factor WAH-1 promotes phosphatidylserine externalization in apoptotic cells through phospholipid scramblase SCRM-1. Nat Cell Biol, 2007, 9 : 541-549.
  • 3Naito M, Nagashima K, Mashima T, et al. Phosphatidylserine ex- ternalization is a downstream event of interleukin-1 beta-converting enzyme family protease activation during apoptosis. Blood, 1997, 89 : 2060-2066.
  • 4Slofstra SH, Spek CA, ten Cate H. Disseminated intravascular co- agulation. Hematol J, 2003, 4 : 295-302.
  • 5Bouchard BA, Tracy PB. Platelets, leukocytes, and coagulation. Curr Opin Hematol, 2001, 8: 263-269.
  • 6George FD. Microparticles in vascular diseases. Thromb Res, 2008, 122 Suppl 1 : S55-59.
  • 7Shi J, Gilbert GE. Lactadherin inhibits enzyme complexes of blood coagulation by competing for phospholipid-binding sites. Blood, 2003, 101 : 2628-2636.
  • 8Shi J, Shi Y, Waehrens LN, et al. Lactadherin detects early phosphatidylserine exposure on immortalized leukemia cells under- going programmed cell death. Cytometry A, 2006, 69: 1193- 1201.
  • 9Shi J, Heegaard CW, Rasmussen JT, et al. Lactadherin binds se- lectively to membranes containing phosphatidyl-L-serine and in- creased curvature. Biochem Biophys Acta, 2004, 1667: 82-90.
  • 10Zhou J, Liu SC, Ma M, et al. Procoagulant activity and phos- phatidylserine of amniotic fluid cells. Thromb Haemost, 2009, 101 : 845-851.

共引文献2

同被引文献145

引证文献15

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部